You have 9 free searches left this month | for more free features.

As2O3

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD With Anxious Distress Trial in Worldwide (JNJ-61393215, Placebo)

Completed
  • Major Depressive Disorder With Anxious Distress
  • Garden Grove, California
  • +34 more
Sep 2, 2022

Crohn's Disease Trial in Worldwide (PF-06651600 Placebo, PF-06651600, Placebo PF-06700841)

Active, not recruiting
  • Crohn's Disease
  • PF-06651600 Placebo
  • +3 more
  • Dothan, Alabama
  • +187 more
Aug 17, 2022

Sarcopenia Trial in Wageningen (Vegan diet (intervention), Omnivorous diet (control))

Recruiting
  • Sarcopenia
  • Vegan diet (intervention)
  • Omnivorous diet (control)
  • Wageningen, Gelderland, Netherlands
    Wageningen University and Research
Dec 1, 2022

Depth of Sedation and Its Impact on Cerebrovascular Reactivity

Not yet recruiting
  • ARDS, Human
  • Masimo O3 NIRS cerebral oximetry and SedLine processed EEG
  • Winnipeg, Manitoba, Canada
    University of Manitoba
Apr 27, 2023

Chemo-induced Peripheral Neuropathy, Pain, Neuropathic, Pain Syndrome Trial in Las Palmas De Gran Canaria (Ozone, Oxygen)

Recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • +2 more
  • Las Palmas De Gran Canaria, Las Palmas, Spain
  • +1 more
Nov 10, 2022

Spondylitis, Ankylosing Trial in Worldwide (CC-99677, Placebo)

Active, not recruiting
  • Spondylitis, Ankylosing
  • Flagstaff, Arizona
  • +139 more
Dec 9, 2022

Schizophrenia Trial in Worldwide (Pimavanserin, Placebo)

Recruiting
  • Schizophrenia
  • Ciudad Autonoma Buenos Aires, Argentina
  • +82 more
Oct 14, 2021

Knee Osteoarthritis Trial in Ankara (Medical ozone injection, steroid injection group)

Recruiting
  • Knee Osteoarthritis
  • Medical ozone injection
  • steroid injection group
  • Ankara, Turkey
    Sefa
Mar 15, 2022

Postmenopausal Osteoporosis Trial in Worldwide (FKS518, US-licensed Prolia)

Active, not recruiting
  • Postmenopausal Osteoporosis
  • Sofia, Sofia City, Bulgaria
  • +75 more
Aug 29, 2022

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Matching to Seltorexant, Quetiapine XR)

Recruiting
  • Depressive Disorder, Major
  • Birmingham, Alabama
  • +212 more
Jul 20, 2022

Esophageal Adenocarcinoma Trial in Buffalo (Carboplatin, 3 Dimensional Conformal Radiation Therapy, Propranolol)

Recruiting
  • Esophageal Adenocarcinoma
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 3, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Focal Onset Seizures Trial in Worldwide (JNJ-40411813, Placebo)

Recruiting
  • Focal Onset Seizures
  • Tucson, Arizona
  • +62 more
May 25, 2022

Pseudomonas Aeruginosa Pneumonia Trial in Worldwide (AR-105, Placebo)

Completed
  • Pseudomonas Aeruginosa Pneumonia
  • Sacramento, California
  • +110 more
Mar 8, 2022

Relapsing-Remitting Multiple Sclerosis (RRMS) Trial in Worldwide (IMU-838 (30 mg/day), IMU-838 (45 mg/day), Placebo)

Active, not recruiting
  • Relapsing-Remitting Multiple Sclerosis (RRMS)
  • IMU-838 (30 mg/day)
  • +3 more
  • Blagoevgrad, Bulgaria
  • +37 more
Jan 19, 2022

Metastatic Colorectal Cancer Trial in Italy (Cetuximab, Avelumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Ancona, Italy
  • +23 more
Oct 25, 2022

Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticaprant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Anhedonia
  • Birmingham, Alabama
  • +156 more
Jan 31, 2023

HER-2 Positive Advanced Solid Tumors Trial (D3L-001)

Not yet recruiting
  • HER-2 Positive Advanced Solid Tumors
  • D3L-001
  • (no location specified)
Jul 20, 2023

Myofascial Pain Syndrome, Myofascial Trigger Point Pain Trial in Ankara (Ozone therapy, Lidocaine injection group)

Completed
  • Myofascial Pain Syndrome
  • Myofascial Trigger Point Pain
  • Ozone therapy
  • Lidocaine injection group
  • Ankara, Turkey
    Gaziler Physical Medicine and Rehabilitation Education and Resea
Jan 14, 2022

Basal Cell Carcinoma, Squamous Cell Carcinoma of Skin Differentiated Trial in London (Hydrogen Peroxide 30 % Topical Solution)

Recruiting
  • Basal Cell Carcinoma
  • Squamous Cell Carcinoma of Skin Differentiated
  • Hydrogen Peroxide 30 % Topical Solution
  • London, Ontario, Canada
    London Regional Cancer Program
Aug 29, 2022

Skin Manifestations Trial in Jakarta Pusat (Sodium Bicarbonate (NaHCO3) Plus Solution, Water (H2o))

Completed
  • Skin Manifestations
  • Sodium Bicarbonate (NaHCO3) Plus Solution
  • Water (H2o)
  • Jakarta Pusat, DKI Jakarta, Indonesia
    dr. Cipto Mangunkusumo General Central National Hospital
Apr 10, 2020

Diabetes, Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)

Recruiting
  • Diabetes
  • Type 2 Diabetes
  • Escondido, California
  • +128 more
Jan 18, 2023

Healthy Trial in Nottingham (BI 685509 oral formulation prototypes, BI 685509 standard oral formulation)

Completed
  • Healthy
  • R1: Reference Product X
  • +12 more
  • Nottingham, United Kingdom
    Quotient Sciences
Dec 7, 2022

SARS-CoV-2 Pneumonia Trial in Durham (Ozone)

Not yet recruiting
  • SARS-CoV-2 Pneumonia
  • Durham, North Carolina
    Duke University Medical Center
Mar 3, 2023

Advanced Cholangiocarcinoma, FGFR2 Gene Rearrangements Trial in Worldwide (TAS-120, Cisplatin/Gemcitabine)

Active, not recruiting
  • Advanced Cholangiocarcinoma
  • FGFR2 Gene Rearrangements
  • Albuquerque, New Mexico
  • +100 more
Feb 1, 2023